STEPHENIE ZINTER: Open Payments
NPI 1174186654 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 24 payments from 9 companies in 2025. Trend: 2023 $627 · 2024 $312 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $120 |
| UROGEN PHARMA, INC. | 4 | $92 |
| Sumitomo Pharma America, Inc. | 3 | $69 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $66 |
| Endo USA, Inc. | 3 | $51 |
| Ferring Pharmaceuticals Inc. | 2 | $46 |
| Teleflex LLC | 1 | $27 |
| Boston Scientific Corporation | 1 | $23 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: ERLEADA, ORGOVYX, JOURNAVX, XIAFLEX, ADSTILADRIN, UROLIFT, AdVance XP, XYOSTED.
Industry payments across MO — which companies pay providers there.
